Andrew Magyar

Andrew Magyar is a biostatistics professional with extensive experience in the biotechnology and pharmaceutical industries, currently serving as the Director of Biostatistics at Bristol Myers Squibb since April 2025, focusing on statistical leadership for neurology portfolio deliverables. Prior experience includes leadership roles at Regeneron and Allergan, overseeing statistical activities, guiding clinical trial designs, and ensuring compliance with regulatory standards. In addition to industry roles, Andrew has been a part-time lecturer at Rutgers University since 2010, teaching a range of undergraduate and master's level statistics courses. Andrew holds a Ph.D. in Statistics from Rutgers University and a B.A. in Mathematics and Economics from the University of Pennsylvania.